Today: 24 January 2026
Subscribe
Browse Category

Company Analysis News 3 December 2025 - 4 December 2025

British American Tobacco (BTI) Stock Near 52‑Week High on 4 December 2025: Dividend Giant, Buybacks and 2026 Outlook

British American Tobacco (BTI) Stock Near 52‑Week High on 4 December 2025: Dividend Giant, Buybacks and 2026 Outlook

British American Tobacco p.l.c. (LSE: BATS, NYSE: BTI) heads into year‑end 2025 in a very different place from the deep‑value gloom of two years ago. The shares are trading close to 52‑week highs, the dividend stream has grown again, buybacks are shrinking the share count, and the company is leaning harder into “smokeless” products such as Vuse vapes, glo heated…
4 December 2025
····
RELX PLC Stock Today: AI‑Powered Growth, Buybacks and 2026 Forecasts

RELX PLC Stock Today: AI‑Powered Growth, Buybacks and 2026 Forecasts

LONDON – 4 December 2025 – RELX PLC (LSE: REL, NYSE: RELX), the data and analytics group behind LexisNexis and ScienceDirect, continues to trade in a consolidation zone despite delivering another year of high‑quality growth, aggressive share buybacks and upbeat analyst forecasts. As of Thursday, RELX shares trade around 3,037p in London and about $40 on the New York Stock…
4 December 2025
····
Zip Co Ltd (ASX: ZIP) Share Price Near $3 as Buyback, Nasdaq Plans and US Inquiry Shape 2026 Outlook

Zip Co Ltd (ASX: ZIP) Share Price Near $3 as Buyback, Nasdaq Plans and US Inquiry Shape 2026 Outlook

Zip Co Ltd (ASX: ZIP) has gone from near‑write‑off to one of the most closely watched growth stocks on the ASX. As of 4 December 2025, the Zip Co share price is hovering around A$3.00, down sharply from recent highs but still reflecting a dramatic multi‑year turnaround in the business. Below is a comprehensive look at the current Zip Co…
4 December 2025
····
CSL Limited (ASX:CSL) Share Price on 4 December 2025: Restructuring Fallout, New Vaccine Plant and 2026 Stock Forecast

CSL Limited (ASX:CSL) Share Price on 4 December 2025: Restructuring Fallout, New Vaccine Plant and 2026 Stock Forecast

Updated: 4 December 2025 CSL Limited (ASX:CSL), the Australian biotech heavyweight, is trading around A$183 per share on 4 December 2025 after one of the most bruising years in its modern history. The company has delivered solid profit growth, announced thousands of job cuts, delayed a major spin‑off, launched a A$750 million buy‑back and opened a A$1 billion cell‑based vaccine…
4 December 2025
···
Eaton Corporation (ETN) Stock Outlook Today: AI Data Centers, Boyd Thermal Deal and 2026 Growth Prospects (3 December 2025)

Eaton Corporation (ETN) Stock Outlook Today: AI Data Centers, Boyd Thermal Deal and 2026 Growth Prospects (3 December 2025)

Eaton Corporation plc (NYSE: ETN) has become one of the most closely watched industrial names in the AI infrastructure boom. As of December 3, 2025, the stock is trading in the mid‑$330s, roughly 17% below its late‑July 52‑week high near $400 after a sharp pullback following earnings and a wave of macro jitters. MarketWatch Yet behind the recent volatility sits…
3 December 2025
····
Amphenol Corporation (APH) Stock on December 3, 2025: AI Datacenter Deals, Insider Sales and Wall Street Forecasts

Amphenol Corporation (APH) Stock on December 3, 2025: AI Datacenter Deals, Insider Sales and Wall Street Forecasts

Amphenol Corporation (NYSE: APH) remains one of the standout performers in large-cap technology hardware as of December 3, 2025, powered by the AI datacenter boom, aggressive M&A and strong institutional demand – but also carrying a valuation that many analysts now describe as “stretched.” Below is a detailed look at where Amphenol stock stands today, the most important news and…
3 December 2025
····
AST SpaceMobile (ASTS) Stock Today: BlueBird 6 Launch Countdown, New Funding and Fresh Price Targets – December 3, 2025

AST SpaceMobile (ASTS) Stock Today: BlueBird 6 Launch Countdown, New Funding and Fresh Price Targets – December 3, 2025

AST SpaceMobile, Inc. (NASDAQ: ASTS) is back on the radar of growth investors as its share price claws higher ahead of a crucial month of satellite launches and investor events. By late morning on December 3, 2025, ASTS is trading around $58 per share, up roughly 2–3% on the day after an 8% surge on December 2 that followed a…
3 December 2025
····
Plug Power (PLUG) Stock in 2025: NASA Contract, Fresh Cash and High‑Risk Forecasts as of December 3, 2025

Plug Power (PLUG) Stock in 2025: NASA Contract, Fresh Cash and High‑Risk Forecasts as of December 3, 2025

Plug Power Inc. (NASDAQ: PLUG) is back in the spotlight. The hydrogen fuel‑cell pioneer has just kicked off its first NASA liquid‑hydrogen contract, closed a $399 million convertible‑note deal that management says “fully funds” its current business plan, and continues to chase profitability under a new leadership trajectory. Times Union At the same time, Plug Power stock is trading near…
3 December 2025
····
Valereum PLC (VLRM) Stock: $200m Financing, US Listing Plans and December 2025 Outlook

Valereum PLC (VLRM) Stock: $200m Financing, US Listing Plans and December 2025 Outlook

Valereum PLC stock has moved from obscure microcap to one of the most talked‑about names on London’s Aquis market in late 2025. A proposed USD $200 million financing package and plans for a US listing have driven a spectacular re‑rating – but also raised big questions about dilution, execution risk and the sustainability of the rally. This article brings together…
3 December 2025
····
Reckitt Benckiser (LON:RKT) Stock Outlook on 3 December 2025: Barclays Upgrade, Buybacks and a $2.2bn Special Dividend

Reckitt Benckiser (LON:RKT) Stock Outlook on 3 December 2025: Barclays Upgrade, Buybacks and a $2.2bn Special Dividend

Reckitt Benckiser Group plc, the FTSE 100 consumer health and hygiene group behind brands like Dettol, Durex, Lysol and Nurofen, is ending 2025 near the top of its trading range – and squarely back on investors’ radar. As of the close on 3 December 2025, Reckitt’s London‑listed shares finished at 5,952p, down 0.47% on the day, but up strongly over…
3 December 2025
····
National Grid plc (NG.) Stock Outlook 2026: Share Price, Dividend, New CEO and £60bn Grid Plan

National Grid plc (NG.) Stock Outlook 2026: Share Price, Dividend, New CEO and £60bn Grid Plan

National Grid plc is ending 2025 in a very “on-brand” way for a regulated utility: quietly near its 52‑week high, raising and spending astonishing sums of money, and sitting at the centre of almost every big energy-transition argument in the UK and US. As of 3 December 2025, investors are weighing a new CEO, a completed LNG divestment, record grid…
3 December 2025
····
Diageo plc Stock Outlook December 2025: Profit Warning, New CEO and What Comes Next for DGE & DEO

Diageo plc Stock Outlook December 2025: Profit Warning, New CEO and What Comes Next for DGE & DEO

Updated: 3 December 2025 – informational only, not investment advice. Where Diageo’s Share Price Stands Today Diageo plc, the Guinness and Johnnie Walker owner listed in London as DGE and in New York as DEO, is limping into December after one of its roughest stretches in a decade. Commentators have not been kind: one recent UK piece described Diageo as…
3 December 2025
···
1 … 45 46 47 48 49 … 67

Stock Market Today

  • ALS Limited's Steady Dividends Reinforce Industrial Sector Appeal on ASX
    January 24, 2026, 1:06 AM EST. ALS Limited (ASX:ALQ) continues to attract investor attention through steady earnings growth, consistent dividend payouts and its established position in Australia's testing, inspection and analytical services sector. Inclusion in the ASX 100 elevates its profile among investors seeking reliable industrial exposures. The company's investment case rests on converting steady demand from mining, life sciences and industrial clients into dependable cash flow and dividends. However, ALS faces risks including a higher debt load, reliance on executing growth and acquisition strategies, and a stretched valuation with a premium earnings multiple. Diverse market views on fair value ranging from A$10.29 to over A$5,500 highlight investor uncertainty. Analysts urge scrutiny of these factors alongside growth prospects before investment decisions.
Go toTop